JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

C5098 CYM 5520

Summary: noncompetitive allosteric agonist of S1P2

≤30 mg/mL
C5023 1H-1-ethyl Candesartan Cilexetil

Summary: selective angiotensin II type 1 receptor (AT1) antagonist

≤30 mg/mL
C5324 U-44069

Summary: TP receptor agonist

≤100 mg/mL
A4127 GSK1070916

Target: Aurora Kinases

Summary: Aurora B/C inhibitor

≥25.4 mg/mL
A1910 Bromodomain Inhibitor, (+)-JQ1
69 Citation

Target: Bromodomains

Summary: BET bromodomain inhibitor

≥22.85 mg/mL
A4349 S- (+)-Rolipram

Summary: CAMP-specific PDE4 inhibitor

insoluble in H2O; ≥13.9 mg/mL
A3371 Doramectin

Summary: Antiparasitic antibiotic

≥89.9 mg/mL
A3778 RS 127445

Summary: 5-HT2B receptor antagonist,high affinity

insoluble in H2O; ≥15.89 mg/mL
B2117 Pioglitazone
1 Citation

Summary: PPAR agonist

insoluble in H2O; insoluble in EtOH; ≥14.3 mg/mL
B1407 Dabrafenib (GSK2118436)
3 Citation

Target: Raf

Summary: Inhibitor of BRAF(V600) mutants

≥26 mg/mL